Hemophilia Spin Off Hemophilia Spin Off (Details) - Bioverativ - USD ($) $ in Millions	Mar. 31, 2017	Feb. 01, 2017
Assets and Liabilities Distributed to Bioverativ [Line Items]
Cash		$ 302.7
Accounts receivable		144.7
Inventory		116.1
Property, plant and equipment, net		20.2
Intangible assets, net		56.8
Goodwill	$ 314.1	314.1
Other, net		53.7
Assets transferred, net		1,008.3
Accrued expenses and other current liabilities		87.8
Other long-term liabilities		67.7
Liabilities transferred, net		$ 155.5